KRAS mouse monoclonal antibody, clone OTI4F6 (formerly 4F6)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Products
KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
| Donor DNA | GFP-puro |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
| Donor DNA | Luciferase-Puro |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
| Donor DNA | GFP-puro |
Kras CRISPRa kit - CRISPR gene activation of mouse Kirsten rat sarcoma viral oncogene homolog
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
KRAS CRISPRa kit - CRISPR gene activation of human KRAS proto-oncogene, GTPase
| Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
| Donor DNA | mBFP-Neo |
Kras - mouse gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
| Donor DNA | Luciferase-Puro |
KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
| Donor DNA | mBFP-Neo |
KRAS - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
KRAS MS Standard C13 and N15-labeled recombinant protein (NP_203524)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
qSTAR qPCR primer pairs against Homo sapiens gene KRAS
qSTAR qPCR primer pairs against Mus musculus gene Kras
KRAS - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
活动过滤器
优化搜索结果
Species
Reactivities
Applications
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
- pCMV6-Entry (26)
- pLenti-C-Myc-DDK-P2A-Puro (4)
- pLenti-C-mGFP-P2A-Puro (4)
- pCMV6-AC-GFP (3)
- pGFP-C-shLenti (3)
- pLenti-C-Myc-DDK (3)
- pLenti-C-mGFP (3)
- pRS (3)
- EF1a-GFP-P2A-Puro (2)
- GFP-puro (2)
- Luciferase-Puro (2)
- RFP-BSD (2)
- mBFP-Neo (2)
- pRFP-C-RS (2)
- PCMV6-Kan/Neo (1)
- pCMV6-XL4 (1)
- pCMV6-XL6 (1)
- pGFP-V-RS (1)
Reporters
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
QC Levels
Families
Pathways
- Acute myeloid leukemia (96)
- Axon guidance (96)
- B cell receptor signaling pathway (96)
- Bladder cancer (96)
- Chemokine signaling pathway (96)
- Chronic myeloid leukemia (96)
- Colorectal cancer (96)
- Dorso-ventral axis formation (96)
- Endometrial cancer (96)
- ErbB signaling pathway (96)
- Fc epsilon RI signaling pathway (96)
- Gap junction (96)
- Glioma (96)
- GnRH signaling pathway (96)
- Insulin signaling pathway (96)
- Long-term depression (96)
- Long-term potentiation (96)
- MAPK signaling pathway (96)
- Melanogenesis (96)
- Melanoma (96)
- Natural killer cell mediated cytotoxicity (96)
- Neurotrophin signaling pathway (96)
- Non-small cell lung cancer (96)
- Pancreatic cancer (96)
- Pathways in cancer (96)
- Progesterone-mediated oocyte maturation (96)
- Prostate cancer (96)
- Regulation of actin cytoskeleton (96)
- Renal cell carcinoma (96)
- T cell receptor signaling pathway (96)
- Thyroid cancer (96)
- Tight junction (96)
- VEGF signaling pathway (96)
